Rahlfs Capital’s Sanofi SNY Stock Holding History

Rahlfs Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,975	Closed	-$387K	–	90
2025 Q1	$387K	Hold	6,975	–	–	0.39%	54
2024 Q4	$336K	Buy	+6,975	New	+$355K	0.33%	56

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rahlfs Capital's SNY Position: Q2 2025 in Review

Rahlfs Capital sold out of Sanofi (SNY) in Q2 2025, closing a stake of 6,975 shares — an estimated $387K sold.

Rahlfs Capital first reported a position in SNY in Q4 2024 and held it in 2 quarters. The position peaked at $387K in Q1 2025. 729 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

Rahlfs Capital reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
Rahlfs Capital sold 6,975 Sanofi shares in Q2 2025, an estimated $387K.
Rahlfs Capital first reported a position in Sanofi in Q4 2024 and held it in 2 quarters.
Rahlfs Capital's Sanofi position peaked at $387K in Q1 2025.
729 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Rahlfs Capital's 13F filing for Q2 2025, filed 11 Aug 2025.